肾脏Glut2功能缺失可逆转糖尿病和肥胖小鼠模型的高血糖并使体重正常化
该研究利用他莫昔芬诱导的CreERT2-Lox系统在小鼠肾脏特异性敲除Glut2(Ks-Glut2 KO),发现肾脏Glut2缺失可改善糖耐量并导致大量尿糖,且在糖尿病和肥胖小鼠模型中逆转高血糖并使体重正常化;机制上,肾脏Glut2缺失后Sglt2表达几乎消失,Hnf1α下调参与调控,提示抑制肾脏GLUT2是糖尿病和肥胖的潜在疗法。
要点
- 肾脏特异性敲除Glut2可改善糖耐量并引起大量尿糖。
- 在糖尿病和肥胖小鼠模型中,诱导肾脏Glut2缺失可逆转高血糖并使体重正常化。
- 肾脏Glut2缺失后Sglt2表达几乎消失,Hnf1α恢复可恢复Sglt2表达。
核心结论
- 肾脏GLUT2与SGLT2之间存在新的交互作用,通过葡萄糖重吸收调节全身葡萄糖稳态。
- 抑制肾脏GLUT2可能是糖尿病和肥胖的潜在疗法。
研究设计与样本
- 使用他莫昔芬诱导的CreERT2-Lox系统在小鼠中肾脏特异性敲除Glut2(Ks-Glut2 KO),并以对照小鼠比较。
- 在不同实验条件下通过OGTT或IVGTT测量循环葡萄糖和胰岛素水平,并定量尿糖水平。
- 使用转录因子阵列识别肾脏GLUT2与SGLT2交互作用的机制。
主要发现
- Ks-Glut2 KO小鼠表现出改善的糖耐量和大量尿糖。
- 当同时敲除肾脏和肝脏Glut2时,血糖控制的改善被消除,提示改善归因于肾脏GLUT2缺失。
- 在糖尿病和肥胖小鼠模型中,诱导肾脏Glut2缺失可逆转高血糖并使体重正常化。
- 诱导肾脏Glut2缺失后3周,Sglt2表达几乎消失。
- 在Ks-Glut2 KO小鼠分离的原代肾脏近端小管细胞中,Hnf1α是下调最显著的基因之一,其恢复可恢复Sglt2表达。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Renal GLUT2 is increased in diabetes, thereby enhancing glucose reabsorption and worsening hyperglycaemia. Here, we determined whether loss of Glut2 (also known as Slc2a2) specifically in the kidneys would reverse hyperglycaemia and normalise body weight in mouse models of diabetes and obesity. METHODS: We used the tamoxifen-inducible CreERT2-Lox system in mice to knockout Glut2 specifically in the kidneys (Ks-Glut2 KO) to establish the contribution of renal GLUT2 to systemic glucose homeostasis in health and in insulin-dependent as well as non-insulin-dependent diabetes. We measured circulating glucose and insulin levels in response to OGTT or IVGTT under different experimental conditions in the Ks-Glut2 KO and their control mice. Moreover, we quantified urine glucose levels to explain the phenotype of the mice independently of insulin actions. We also used a transcription factor array to identify mechanisms underlying the crosstalk between renal GLUT2 and sodium-glucose cotransporter 2 (SGLT2). RESULTS: The Ks-Glut2 KO mice exhibited improved glucose tolerance and massive glucosuria. Interestingly, this improvement in blood glucose control was eliminated when we knocked out Glut2 in the liver in addition to the kidneys, suggesting that the improvement is attributable to the lack of renal GLUT2. Remarkably, induction of renal Glut2 deficiency reversed hyperglycaemia and normalised body weight in mouse models of diabetes and obesity. Longitudinal monitoring of renal glucose transporters revealed that Sglt2 (also known as Slc5a2) expression was almost abolished 3 weeks after inducing renal Glut2 deficiency. To identify a molecular basis for this crosstalk, we screened for renal transcription factors that were downregulated in the Ks-Glut2 KO mice. Hnf1α (also known as Hnf1a) was among the genes most downregulated and its recovery restored Sglt2 expression in primary renal proximal tubular cells isolated from the Ks-Glut2 KO mice. CONCLUSIONS/INTERPRETATION: Altogether, these results demonstrate a novel crosstalk between renal GLUT2 and SGLT2 in regulating systemic glucose homeostasis via glucose reabsorption. Our findings also indicate that inhibiting renal GLUT2 is a potential therapy for diabetes and obesity.
引用
- de Souza Cordeiro LM, Bainbridge L, Devisetty N, et al. Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity. Diabetologia. 2022. PMID: 35290476. doi:10.1007/s00125-022-05676-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。